Monosaccaridi

2,3,5-Tri-O-benzyl-1-O-(4-nitrobenzoyl)-L-arabinofuranose is a custom synthesis that is modified with fluorination, methylation, and monosaccharide. It is synthesized to be a carbohydrate molecule. This product has CAS No. and can be used in the modification of other molecules that are carbohydrates. This product can be found in oligosaccharides and saccharides as well as complex carbohydrates.

1-Amino-1,5-dideoxy-L-erythro-2-pentulose is a glycoconjugate that contains an amino sugar. It is also a complex carbohydrate that is methylated and fluorinated. 1-Amino-1,5-dideoxy-L-erythro-2-pentulose is a polysaccharide made up of saccharides and oligosaccharides. The saccharides in this compound are modified with the addition of sugars (e.g., glycosylation). This product has been custom synthesized to order and can be ordered as a high purity product.

Methyl 2,4,6-tri-O-acetyl-b-D-glucopyranoside is a modified sugar that is synthesized by a click reaction. This compound has been shown to be an efficient glycosylide donor for the synthesis of complex carbohydrates. Methyl 2,4,6-tri-O-acetyl-b-D-glucopyranoside has been used in the synthesis of oligosaccharides and glycosylated proteins.

4-Methoxyphenyl 2,4,6-tri-O-acetyl-3-O-benzyl-b-D-glucopyranoside is a water soluble glycosaminoglycan. It is a crosslink between chondroitin sulfate and heparan sulfate proteoglycans. It has been found to be expressed in the tissues of the intestine, liver and other organs. 4MPTBAG is used as a marker for intestinal metaplasia and colorectal cancer. The expression of this glycosaminoglycan has also been shown to be increased in liver metastases from cancers of the breast or colon.

Phenyl 2-O-benzoyl-3-O-benzyl-4-O-levulinoyl-b-D-thioglucuronide methyl ester is a high purity, custom synthesis, sugar that has been click modified with fluorination. It can be used in glycosylation and synthetic modification. The CAS number for this compound is 123456. It is an oligosaccharide that contains saccharides, carbohydrates, and complex carbohydrates.

D-Galactose diethyldithioacetal is a phenylhydrazone that has an affinity for the C-3 position of sugars. It is synthesised from D-galactose and diethyldithiocarbonyl chloride, with a borohydride reduction to give the hydroxyl group. The hydroxyl group reacts with methyl glycosides or carbohydrates to produce 3-substituted glycosides or 3-substituted carbohydrate. D-Galactose diethyldithioacetal also inhibits glycosidase enzymes, which are enzymes that break down sugars, and thus prevents the digestion of sugars. The chemical structure of D-galactose diethyldithioacetal was determined by magnetic resonance spectroscopy. The product was found to be L-fucitol (a sweetener) after desulfurization using hydrogen gas for removal of sulfur compounds.

D-Glucitol-2-13C is a stable isotope-labeled analog of mannitol, which is a sugar alcohol used as an osmotic diuretic. It has been shown to have anticancer properties by inducing apoptosis in cancer cells. D-Glucitol-2-13C has been used as a metabolic tracer in studies investigating tumor metabolism and the effects of kinase inhibitors on cancer cell proliferation. This compound can be detected using luciferase-based assays and has potential as a diagnostic tool for cancer detection. Additionally, D-Glucitol-2-13C has been found in Chinese urine samples and may have a role in protein metabolism. Overall, this compound shows promise as an important tool in cancer research and diagnosis.

Naproxen is a non-steroidal anti-inflammatory drug (NSAID) that is used to relieve pain and reduce inflammation. The NSAIDs are metabolized in the liver by oxidation, reduction, hydrolysis, or conjugation with glucuronic acid. Naproxen undergoes a number of metabolic transformations including fragmentation, which can be detected using an MS/MS analyzer. Naproxen acyl-b-D-glucuronide is an oxidative metabolite of naproxen that has been shown to have high uptake into mammalian cells and bioconcentrates in fish. This metabolite has also been shown to be metabolized in the liver by conjugation with glucuronic acid.